Siga Technologies (SIGA) Income towards Parent Company (2010 - 2025)
Siga Technologies' (SIGA) quarterly Income towards Parent Company came in at -$6.4 million in Q3 2025, down 573.67% YoY from $1.3 million in Q3 2024, and down 117.95% on a QoQ basis from $35.5 million in Q2 2025.
Siga Technologies (SIGA) Income towards Parent Company (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Income towards Parent Company data on file, last reported at -$6.4 million in Q3 2025.
- Quarterly Income towards Parent Company fell 573.67% year-over-year to -$6.4 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $28.7 million (down 51.44% YoY) and the FY2024 annual result came in at $59.2 million, down 13.01% from the prior year.
- Income towards Parent Company eased to -$6.4 million in Q3 2025, from $35.5 million in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of $73.4 million in Q4 2021 to a low of -$6.4 million in Q3 2025.
- A 5-year average of $13.6 million and a median of -$258928.0 in 2021 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2023 — Income towards Parent Company surged 9000.73% — and 2025, when it sank 573.67%.
- Tracing SIGA's Income towards Parent Company over 5 years: stood at $73.4 million in 2021, then tumbled by 101.11% to -$811794.0 in 2022, then surged by 9000.73% to $72.3 million in 2023, then sank by 36.67% to $45.8 million in 2024, then sank by 113.91% to -$6.4 million in 2025.
- The last three Income towards Parent Company figures came in at -$6.4 million (Q3 2025), $35.5 million (Q2 2025), and -$370415.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Siga Technologies | 213.74 Mn | 58.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -6.37 Mn |
| Jun 30, 2025 | 35.47 Mn |
| Mar 31, 2025 | -370,415.00 |
| Dec 31, 2024 | 45.76 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 10.28 Mn |
| Dec 31, 2023 | 72.26 Mn |
| Sep 30, 2023 | -393,066.00 |
| Jun 30, 2023 | -2.88 Mn |
| Mar 31, 2023 | -917,677.00 |
| Dec 31, 2022 | -811,794.00 |
| Sep 30, 2022 | 33.04 Mn |
| Jun 30, 2022 | 1.99 Mn |
| Mar 31, 2022 | -361,049.00 |
| Dec 31, 2021 | 73.38 Mn |
| Sep 30, 2021 | -3.11 Mn |
| Jun 30, 2021 | -258,928.00 |
| Mar 31, 2021 | -1.73 Mn |
| Dec 31, 2020 | 20.16 Mn |